News & Events about Dexcom Inc.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the companys second Super Bowl commercial, which announces the US launch of its next-generation Dexcom G7 CGM System. The ad, which will run during the second quarter of...
DexCom, Inc. (NASDAQ:DXCM Get Rating) CEO Kevin R. Sayer sold 45,607 shares of DexCom stock in a transaction on Friday, January 20th. The shares were sold at an average price of $105.75, for a total value of $4,822,940.25. Following the completion of the transaction, the chief executive ...
DexCom, Inc. (NASDAQ:DXCM Get Rating) CEO Kevin R. Sayer sold 45,607 shares of the businesss stock in a transaction dated Friday, January 20th. The stock was sold at an average price of $105.75, for a total value of $4,822,940.25. Following the sale, the chief executive officer now directly owns 426...
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023. The live presentation is scheduled to begin at approximately 2:15 PM EST and...
Shares of DexCom, Inc. (NASDAQ:DXCM Get Rating) have been assigned a consensus recommendation of Moderate Buy from the nineteen analysts that are currently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a ...